Cameco (NYSE:CCJ) Trading Down 4.1% - Should You Sell?

Key Points

• Cameco shares fell 4.1% intraday to about $118.73 on Thursday, with volume (~3.04M shares) ~22% below the daily average, a move attributed to sector-wide profit-taking after a recent rally.
• Analyst sentiment is mostly constructive—consensus rating "Moderate Buy" with an average price target of $153.13—and firms like Scotiabank and Stifel issued higher targets ($175 and C$180), although Weiss downgraded to Hold and Scotiabank trimmed a FY2027 EPS estimate.
• Cameco reported a Q1 beat (EPS $0.34 vs. $0.29) and shows strong liquidity and low leverage, but it trades at a rich valuation (P/E ≈110), which could increase near-term volatility despite positive fundamentals.

Cameco Corporation (NYSE:CCJ - Get Free Report) TSE: CCO's share price dropped 4.1% during mid-day trading on Thursday . The stock traded as low as $118.03 and last traded at $118.7280. Approximately 3,039,817 shares were traded during trading, a decline of 22% from the average daily volume of 3,900,200 shares. The stock had previously closed at $123.76.

More Cameco News

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: Bay Street support: Scotiabank recently raised Cameco’s price target to $175, citing accelerating demand for nuclear fuel, and bullish write-ups emphasize CCJ’s strong Q1 and strategic positioning. Scotiabank Just Hiked Cameco Price Target to $175
• Positive Sentiment: Stifel Canada maintained a Buy on CCJ and kept a C$180 target after Q1 results, supporting upside from institutional coverage. Cameco Maintained at Buy at Stifel Canada Following Q1 Results
• Positive Sentiment: Investor commentary highlights durable tailwinds — uranium market strength, vertical integration (Westinghouse stake) and a strong Q1 — which underpin medium/long-term bullish thesis. The World Is Going Nuclear And Cameco Is Ready
• Neutral Sentiment: Management commentary: Cameco’s shareholder/analyst call transcript reiterates strategy and operational updates but contained no major new guidance surprises. Cameco Shareholder/Analyst Call Prepared Remarks Transcript
• Neutral Sentiment: Sector catalysts: regulatory wins for peers (e.g., Oklo’s NRC approval) have driven volatile rotation into small-cap reactor names and contributed to broader trading volatility that can spill into large-cap uranium names like CCJ. Oklo Advances 12% on NRC Aurora Approval
• Negative Sentiment: Short-term profit-taking: after a sharp rally across nuclear stocks, CCJ is slipping amid sector-wide pullback (investors trimming gains). NANO Nuclear Slides 10%, Oklo Falls 8%, Cameco Slips 4% After Nuclear Stocks Explosive Rally
• Negative Sentiment: Analyst estimate cut: Scotiabank trimmed its FY2027 EPS forecast modestly, which can weigh on near-term expectations despite an overall constructive rating. Scotiabank Reduced FY2027 EPS Estimate for Cameco

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. The Goldman Sachs Group reiterated a "buy" rating and issued a $131.00 price objective on shares of Cameco in a research report on Wednesday, February 4th. Glj Research reiterated a "buy" rating and issued a $171.20 price objective (up from $100.00) on shares of Cameco in a research report on Wednesday, February 18th. Weiss Ratings lowered Cameco from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Wednesday. Scotiabank reiterated an "outperform" rating and issued a $175.00 price objective on shares of Cameco in a research report on Wednesday. Finally, Sanford C. Bernstein reiterated an "outperform" rating and issued a $147.00 price objective on shares of Cameco in a research report on Thursday, February 5th. Eleven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $153.13.

Cameco Trading Down 4.1%

The company has a market cap of $51.71 billion, a price-to-earnings ratio of 109.93, a P/E/G ratio of 2.12 and a beta of 1.04. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.68 and a current ratio of 2.47. The firm has a fifty day moving average price of $114.92 and a 200 day moving average price of $105.75.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last released its quarterly earnings data on Tuesday, May 5th. The basic materials company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.29 by $0.05. The company had revenue of $607.49 million during the quarter, compared to the consensus estimate of $598.63 million. Cameco had a return on equity of 11.19% and a net margin of 18.38%.The firm's revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.16 EPS. As a group, equities analysts predict that Cameco Corporation will post 1.2 EPS for the current fiscal year.

Institutional Investors Weigh In On Cameco

Large investors have recently made changes to their positions in the stock. Nisa Investment Advisors LLC bought a new stake in Cameco in the 4th quarter valued at $25,000. Founders Capital Management bought a new stake in Cameco in the 4th quarter valued at $27,000. Strategic Advocates LLC bought a new stake in Cameco in the 3rd quarter valued at $28,000. Mcguire Capital Advisors Inc. bought a new stake in Cameco in the 4th quarter valued at $28,000. Finally, Caitong International Asset Management Co. Ltd raised its stake in Cameco by 30,700.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 308 shares of the basic materials company's stock valued at $28,000 after acquiring an additional 307 shares during the period. Institutional investors and hedge funds own 70.21% of the company's stock.

About Cameco

Cameco Corporation NYSE: CCJ is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company's operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.